Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bowel Preparation for Colonoscopy May Lead to a Higher Feasibility of Intestinal Infection
NCT05277090Phase 1Unknown
- Start
- Mar 2022
- Primary completion
- Mar 2022
- Modality
- Injectable Hydrogels, Microbiome Therapeutics, Implantable Hydrogels
01
Overview
Phase 1 trial of polyethylene glycol 3350 and inulin in intestinal infection and Gut microbiota dysbiosis (3 arms). Primary endpoint: Changes in the intestinal flora caused by polyethyleneglycol at 1 year. Status: unknown.
02
Drugs
polyethylene glycol 3350inulin
03
Conditions
intestinal infectionGut microbiota dysbiosis
Beyond the preview
Go deeper on NCT05277090.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05277090.